x

Search for a clinical trial

* (*) mandatory field

27 Result(s)

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

AUSTRIA

NIEDERÖSTERREICH
VIENNA

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberHCQ4Surfdefect: Hydroxychloroquine (HCQ) in pediatric ILD (interstitial lung disease) - AT
FWF - Austrian Science Fund
ERA-Net for research programs on rare diseases - Austria

FRANCE

ILE-DE-FRANCE
PARIS

Ongoing trial
Funded by an IRDiRC memberROCK-ALS: Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALS - FR
ANR - Agence Nationale de la Recherche
ERA-Net for research programs on rare diseases - France

GERMANY

Nordrhein-Westfalen
BONN

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberROCK-ALS: Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS -DE-
Projektträger im Deutschen Zentrum für Luft- und Raumfahrt
ERA-Net for research programs on rare diseases - Germany

SWITZERLAND

Suisse Alémanique
BERN

SWITZERLAND

Suisse Alémanique
BERN

SWITZERLAND

Suisse Alémanique
BERN

SWITZERLAND

Suisse Alémanique
BERN

SWITZERLAND

Suisse Alémanique
BERN

Ongoing trial
Funded by an IRDiRC memberROPROP: Oral Propranolol for prevention of thresholdretinopathy of prematurity - CH
SNSF- Swiss National Science Foundation
ERA-Net for research programs on rare disease - Switzerland

SWITZERLAND

Suisse Alémanique
BERN

SWITZERLAND

Suisse Alémanique
BERN

Ongoing trial
Funded by an IRDiRC memberROPROP: Oral Propranolol for prevention of thresholdretinopathy of prematurity - DE
SNSF- Swiss National Science Foundation
ERA-Net for research programs on rare disease - Switzerland

SWITZERLAND

Suisse Alémanique
BERN

SWITZERLAND

Suisse Alémanique
BERN

Multinational clinical trial(s)

GERMANY

Bayern
MÜNCHEN

Funded by an IRDiRC memberROCK-ALS: Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALS
Klinikum rechts der Isar der Technischen Universität München
Neurologische Klinik und Poliklinik

GERMANY

Berlin
BERLIN

GERMANY

Berlin
BERLIN

Funded by an IRDiRC memberROPROP: Oral Propranolol for prevention of thresholdretinopathy of prematurity
Charité - Universitätsmedizin Berlin (CCM)
Klinik für Neonatologie

GERMANY

Niedersachsen
GÖTTINGEN

GERMANY

Nordrhein-Westfalen
BONN

Funded by an IRDiRC memberROCK-ALS: Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALS
Projektträger im Deutschen Zentrum für Luft- und Raumfahrt
ERA-Net for research programs on rare diseases - Germany

GERMANY

Nordrhein-Westfalen
BONN

Funded by an IRDiRC memberROPROP: Oral Propranolol for prevention of thresholdretinopathy of prematurity
Projektträger im Deutschen Zentrum für Luft- und Raumfahrt
ERA-Net for research programs on rare diseases - Germany

SWITZERLAND

Suisse Alémanique
BERN

Funded by an IRDiRC memberTAMDMD (Tamoxifen in Duchenne muscular dystrophy): Multicentre, randomised, double-blind, placebo-controlled, phase 3 safety and efficacy 48-week trial
SNSF- Swiss National Science Foundation
ERA-Net for research programs on rare disease - Switzerland